New Animal Drugs; Trilostane

• Date: November 05, 2009
• Source: www.fda.gov

The Food and Drug  Administration (FDA) is amending the  animal drug regulations to reflect the  original approval of a new animal drug  application (NADA) filed by Dechra,  Ltd. The NADA provides for the  veterinary prescription use of trilostane  capsules in dogs for treatment of  pituitary-dependent  hyperadrenocorticism and for treatment  of hyperadrenocorticism due to  adrenocortical tumor

Effective Date:This rule is effective May 11,2009

Click here to download the file